The value of serum RASSF10 hypermethylation as a diagnostic and prognostic tool for gastric cancer

[1]  Ning Zhang,et al.  Ras association domain family member 10 suppresses gastric cancer growth by cooperating with GSTP1 to regulate JNK/c-Jun/AP-1 pathway , 2016, Oncogene.

[2]  P. Li,et al.  Low expression of fibulin-1 correlates with unfavorable prognosis in gastric cancer , 2016, Tumor Biology.

[3]  P. Li,et al.  RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma , 2015, Oncotarget.

[4]  Joon-Oh Park,et al.  Clinical Significance of IGFBP-3 Methylation in Patients with Early Stage Gastric Cancer , 2015, Translational oncology.

[5]  T. Tahara,et al.  DNA methylation as a molecular biomarker in gastric cancer. , 2015, Epigenomics.

[6]  J. Herman,et al.  RASSF10 suppresses colorectal cancer growth by activating P53 signaling and sensitizes colorectal cancer cell to docetaxel , 2015, Oncotarget.

[7]  M. Plummer,et al.  Global burden of gastric cancer attributable to Helicobacter pylori , 2015, International journal of cancer.

[8]  Jun Yu,et al.  Methylation of ras association domain protein 10 (RASSF10) promoter negative association with the survival of gastric cancer. , 2014, American Journal of Cancer Research.

[9]  M. May.  Statistics: Attacking an epidemic , 2014, Nature.

[10]  A. Kaneda,et al.  DNA methylation in gastric cancer, related to Helicobacter pylori and Epstein-Barr virus. , 2014, World journal of gastroenterology.

[11]  W. Meng,et al.  Helicobacter pylori-induced gastric inflammation and gastric cancer. , 2014, Cancer letters.

[12]  Qiang Sun,et al.  RASSF10 is an epigenetically silenced tumor suppressor in gastric cancer. , 2014, Oncology reports.

[13]  D. Ilson.  Angiogenesis in gastric cancer: hitting the target? , 2014, The Lancet.

[14]  Satoshi Morita,et al.  Disease-free survival as a surrogate for overall survival in adjuvant trials of gastric cancer: a meta-analysis. , 2013, Journal of the National Cancer Institute.

[15]  Peng Hou,et al.  Gene methylation in gastric cancer. , 2013, Clinica chimica acta; international journal of clinical chemistry.

[16]  A. Thompson,et al.  Methylated tissue factor pathway inhibitor 2 (TFPI2) DNA in serum is a biomarker of metastatic melanoma. , 2013, The Journal of investigative dermatology.

[17]  Xudong Xu,et al.  RASSF10 is epigenetically silenced and functions as a tumor suppressor in gastric cancer. , 2013, Biochemical and biophysical research communications.

[18]  R. Burbano,et al.  DNA and histone methylation in gastric carcinogenesis. , 2013, World journal of gastroenterology.

[19]  I. Talaat,et al.  Free Circulating Tumor DNA as a Diagnostic Marker for Breast Cancer , 2012, Journal of clinical laboratory analysis.

[20]  R. Dammann,et al.  Epigenetic down regulation of RASSF10 and its possible clinical implication in prostate carcinoma , 2012, The Prostate.

[21]  Bin Tean Teh,et al.  Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes , 2012, Nature Genetics.

[22]  A. Enk,et al.  RASSF10 promoter hypermethylation is frequent in malignant melanoma of the skin but uncommon in nevus cell nevi. , 2012, The Journal of investigative dermatology.

[23]  Jun Yu,et al.  Characterization of the gene structure, functional significance, and clinical application of RNF180, a novel gene in gastric cancer , 2012, Cancer.

[24]  Emma Donald,et al.  Comparison of KRAS Mutation Assessment in Tumor DNA and Circulating Free DNA in Plasma and Serum Samples , 2012, Clinical medicine insights. Pathology.

[25]  V. Hill,et al.  Epigenetic inactivation of the RASSF10 candidate tumor suppressor gene is a frequent and an early event in gliomagenesis , 2011, Oncogene.

[26]  Hong Lin,et al.  Quantitative detection of multiple gene promoter hypermethylation in tumor tissue, serum, and cerebrospinal fluid predicts prognosis of malignant gliomas. , 2010, Neuro-oncology.

[27]  R. Dammann,et al.  Frequent epigenetic inactivation of RASSF10 in thyroid cancer , 2009, Epigenetics.

[28]  Raffaella Chiaramonte,et al.  The novel RASSF6 and RASSF10 candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukaemias , 2009, Molecular Cancer.

[29]  C. Sakakura,et al.  Quantitative analysis of tumor-derived methylated RUNX3 sequences in the serum of gastric cancer patients. , 2009, Anticancer research.

[30]  M. T. McCabe,et al.  Cancer DNA Methylation: Molecular Mechanisms and Clinical Implications , 2009, Clinical Cancer Research.

[31]  D. Roukos,et al.  Epigenetics in Gastric Cancer: Challenges for Clinical Implications , 2009, Annals of Surgical Oncology.

[32]  Ren-Min Zhu,et al.  Detection of RASSF1A promoter hypermethylation in serum from gastric and colorectal adenocarcinoma patients. , 2008, World journal of gastroenterology.

[33]  Mohammad Reza Abbaszadegan,et al.  p16 promoter hypermethylation: a useful serum marker for early detection of gastric cancer. , 2008, World journal of gastroenterology.

[34]  A. Chalmers,et al.  RASSF7 is a member of a new family of RAS association domain-containing proteins and is required for completing mitosis. , 2008, Molecular biology of the cell.

[35]  W. Holzgreve,et al.  Positive correlation of cell-free DNA in plasma/serum in patients with malignant and benign breast disease. , 2008, Anticancer research.

[36]  T. Brzozowski,et al.  Melatonin in gastroprotection against stress-induced acute gastric lesions and in healing of chronic gastric ulcers. , 2006, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[37]  T. Brzozowski,et al.  Gastric cancer and Helicobacter pylori infection. , 2006, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[38]  Nobuyuki Tani,et al.  Correlation between serum DNA methylation and prognosis in gastric cancer patients. , 2006, Anticancer research.

[39]  F. Chan,et al.  Potential diagnostic and prognostic values of detecting promoter hypermethylation in the serum of patients with gastric cancer , 2005, British Journal of Cancer.

[40]  D. Roder,et al.  The epidemiology of gastric cancer , 2002, Gastric Cancer.

[41]  I. Pak,et al.  Gastric cancer and Helicobacter pylori infection , 1993, The British journal of surgery.

[42]  Mohamad Amin Pourhoseingholi,et al.  Burden of gastrointestinal cancer in Asia; an overview , 2015, Gastroenterology and hepatology from bed to bench.

[43]  M. Coleman,et al.  Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study. , 2014, The Lancet. Oncology.